• RESEARCH

    CRISPR-Cas9 electroporation targets KRAS G12V mutation in CRC cells

    Researchers used direct electroporation of Cas9 ribonucleoproteins to achieve allele-specific disruption of KRAS p.G12V in SW480 colorectal cancer cells, assessing delivery efficiency and on-target editing. (Iranian Journal of Basic Medical Sciences)